Gemcitabine elaidate
CAS No. | 210829-30-4 | Cat. No. | BCP07317 |
Name | Gemcitabine elaidate | ||
Synonyms | CO-101; CP-4126; CO 101; CP 4126; CO101; CP4126; Gemcitabine 5'-elaidate; | ||
Formula | C27H43F2N3O5 | M. Wt | 527.64 |
Description | Gemcitabine elaidate (also known as CO-101; CP-4126) is a lipophilic, unsaturated fatty acid ester derivative of gemcitabine (dFdC), an antimetabolite deoxynucleoside analogue, with potential antineoplastic activity. Upon hydrolysis intracellularly by esterases, the prodrug gemcitabine is converted into the active metabolites difluorodeoxycytidine di- and tri-phosphate (dFdCDP and dFdCTP) by deoxycytidine kinase. dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide po | ||
Pathways | Cell Cycle/DNA Damage | ||
Targets | DNA/RNA Synthesis Antimetabolite |
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.